Background

Magnesium deficiency is associated with a number of adverse outcomes during pregnancy, including gestational hypertension and preterm birth. This study examined how magnesium supplementation affected outcomes in pregnant women.

The study

This randomized controlled trial included 407 pregnant women in Brazil. Women in the treatment group received 300 mg of magnesium citrate per day from 12 to 20 weeks of gestation. Researchers tracked pregnancy outcomes.

The results

There was no significant difference in outcomes for mother or child between the magnesium and placebo groups.

Every month we summarize over 150 of the most noteworthy health and nutrition studies. Other health categories related to this summary include:Try Examine+ for free to view the latest research in 25 health categories and the entire Study Summaries archive, access our Supplement Guides, and unlock the Examine Database. Plus, earn continuing education credits!

Get free weekly updates on what’s new at Examine.

This Study Summary was published on August 6, 2020.